In the majority of acromegalics, if octreotide is administered subcutaneously in doses of 300-600┬╡g per day (100-200┬╡g eight hourly), GH levels are suppressed (Fig. 3.25) such that fifty-five per cent of patients have average levels below 10mu/l, compared to fourteen per cent with bromocriptine.
